UEG Week 2025
Berlin, Germany, 04 - 07 Oct 2025
UEG Week combines world-class scientific research and invited lectures by leading minds in gastroenterology. For the first time, in 2025, the event is bringing the Digestive Disease Mechanism (DDM) Summit, an additional 3-day programme focusing on the Pathogenesis of GI tract diseases (including cancer).
Owlstone Medical will be attending and presenting at the event. Our poster, ‘Targeted Analysis of Volatile Metabolites from the Gut Microbiome in Exhaled Breath,’ will be presented in the Nutrition section.
Please come and meet our team at Booth 2.10 in Hall 2.2 to discuss how our Breath Biopsy platform and OMED Health Breath Analyzer could help to support your biomarker discovery research.
Meet the Team
Dr Huw Davies has over 30 years experience working with novel technologies that enable the diagnosis and treatment of major human diseases. In his current role, Huw leads a global commercial team responsible for growing Owlstone Medical’s Breath Biopsy®collaborations and service business with leading pharmaceutical companies and academic partners to identify and deploy novel non-invasive breath biomarkers for precision medicine and disease diagnosis.
Dr Ben Constant is a Business Development Executive at Owlstone Medical, where he is dedicated to advancing breath biomarker research.
Ben completed his undergraduate studies in Biomedical Sciences at the University of Sheffield, before pursuing a PhD at the University of Cambridge under the supervision of Dr Wei Li in the Department of Medicine. His doctoral research focused on elucidating the mechanisms of action of a novel pharmaceutical treatment for obesity.
Ben has a diverse background in the medical technology sector. He previously worked at Ortho Clinical Diagnostics, where he contributed to the development of a diagnostic test for heart attacks. Additionally, he has served as a technical consultant, assisting MedTech innovators in bringing their cutting-edge technologies to market.
In his current role, Ben is passionate about collaborating with leading scientists across Europe and Asia, helping them explore how breath biomarkers can enhance their research and clinical outcomes.
